"Humor book" provides release for nurses.

C. Menke

1993-07-01

Oncology Nursing Forum

Abstract:

What problem does this paper attempt to address?

Cycles of Learning in the Centipede Game

Giovanni Ponti

DOI: https://doi.org/10.1006/game.1998.0707

Abstract:Traditional game theoretic analysis often proposes the application of backward induction and subgame-perfection as models of rational behaviour in games with perfect information. However, there are many situations in which such application leads to counterinitiative results, casting doubts on the predictive power of theory itself. The Centipede Game, firstly, introduced by Rosenthal (1981), represents one of the critical cases and experimental evidence has been provided to show how people in laboratory behave in a manner which is a significatively different from what the theory expects. In our paper, we construct a dynamic model based on the Centipede Game. Our claim is that the source of these discrepancies between theory and experimental evidence may be explained by appealing to some form of bounded rationality in the players' reasoning. If this is the case, traditional game theoretical analysis could still accurately predict the players' behaviour, provided that they are given time enough to correctly perceive the strategic environment in which they operate. to do so, we provide conditions for convergence to the subgame-perfect equilibrium outcome for a broad class of continuous time evolutionary dynamics, defined as Aggregate Monotonic Selection dynamics(Samuelson and Zhang 1992). Moreover, by introducing a drift term in the dynamics, we show how the outcome of this learning process is intrinsically unstable, and how this instability is positively related with the length of the game.
Osteoclast-derived Exosomal Mir-214-3p Inhibits Osteoblastic Bone Formation.

Defang Li,Jin Liu,Baosheng Guo,Chao Liang,Lei Dang,Cheng Lu,Xiaojuan He,Hilda Yeuk-Siu Cheung,Liang Xu,Changwei Lu,Bing He,Biao Liu,Atik Badshah Shaikh,Fangfei Li,Luyao Wang,Zhijun Yang,Doris Wai-Ting Au,Songlin Peng,Zongkang Zhang,Bao-Ting Zhang,Xiaohua Pan,Airong Qian,Peng Shang,Lianbo Xiao,Baohong Jiang,Chris Kong-Chu Wong,Jiake Xu,Zhaoxiang Bian,Zicai Liang,De-an Guo,Hailong Zhu,Weihong Tan,Aiping Lu,Ge Zhang

DOI: https://doi.org/10.1038/ncomms10872

IF: 16.6

2016-01-01

Nature Communications

Abstract:Emerging evidence indicates that osteoclasts direct osteoblastic bone formation. MicroRNAs (miRNAs) have a crucial role in regulating osteoclast and osteoblast function. However, whether miRNAs mediate osteoclast-directed osteoblastic bone formation is mostly unknown. Here, we show that increased osteoclastic miR-214-3p associates with both elevated serum exosomal miR-214-3p and reduced bone formation in elderly women with fractures and in ovariectomized (OVX) mice. Osteoclast-specific miR-214-3p knock-in mice have elevated serum exosomal miR-214-3p and reduced bone formation that is rescued by osteoclast-targeted antagomir-214-3p treatment. We further demonstrate that osteoclast-derived exosomal miR-214-3p is transferred to osteoblasts to inhibit osteoblast activity in vitro and reduce bone formation in vivo. Moreover, osteoclast-targeted miR-214-3p inhibition promotes bone formation in ageing OVX mice. Collectively, our results suggest that osteoclast-derived exosomal miR-214-3p transfers to osteoblasts to inhibit bone formation. Inhibition of miR-214-3p in osteoclasts may be a strategy for treating skeletal disorders involving a reduction in bone formation.
Effect of primary osteoblast-derived extracellular vesicles on osteoclast differentiation

Lan Zhang,Jingyi Tan

DOI: https://doi.org/10.3724/zdxbyxb-2024-0148

2024-08-25

Abstract:Objectives: To investigate the effect of osteoblast-derived extracellular vesicles (OB-EVs) on the proliferation and differentiation of osteoclasts, and to explore the possible molecular mechanism of extracellular vesicles involved in the communication between osteoblasts and osteoclasts. Methods: Primary osteoblasts were isolated from newborn mouse calvarial bone and induced by β-glycero phosphate, ascorbic acid and dexamethasone. Osteogenic feature was tested by alkaline phosphatase (ALP) and alizarin red S staining. Extracellular vesicles were isolated by ultracentrifugation from the cell culture supernatant. Vesicle morphology was observed by transmission electron microscopy, and the characteristic markers of tumor susceptibility gene 101 (TSG101), ALG-2 interacting protein X (Alix) and cluster of differentiation 9 (CD9) on the surface of extracellular vesicles were identified by Western blotting. Cell counting kit 8 (CCK-8) assay was used to determine the proliferation effect of OB-EVs on mouse mononuclear macrophage RAW264.7 cells. Furthermore, the expression level of specific markers of osteoclast differentiation in RAW264.7 cells was detected by Western blotting after the combined effect of OB-EVs and receptor activator for nuclear factor κB ligand (RANKL). The number of osteoclasts was observed and compared with OB-EVs-treated mouse bone marrow-derived macrophages (BMMs) by tartrate-resistant acid phosphatase (TRAP) staining, and the effect of OB-EVs on osteoclast differentiation was determined. Results: The extracted OB-EVs showed a double-layer cup-like structure with a diameter of 30-150 nm, and TSG101, Alix and CD9 were expressed. RAW264.7 cells were stimulated with OB-EVs, and the results of CCK-8 assay showed that high concentration of OB-EVs (more than 20 μg/mL) inhibited cell proliferation (P<0.05). Western blotting analysis showed that the expression of osteoclast differentiation marker proteins such as c-Fos, activated T cell nuclear factor (NFATc1) and c-Jun N-terminal kinase (JNK) in RAW264.7 cells were significantly increased, and the promoting effect was enhanced with increasing of OB-EVs concentration (P<0.05). In addition, the combination of OB-EVs and RANKL on BMMs showed that the number of TRAP-positive cells was significantly higher than that of the RANKL induction group alone (P<0.05). Conclusions: OB-EVs can promote the differentiation of osteoclast precursor cells into osteoclasts, but high concentration of OB-EVs can inhibit proliferation of RAW264.7 cells.
Osteoblast‐Derived Extracellular Vesicles Are Biological Tools for the Delivery of Active Molecules to Bone

N. Rucci,Alexander E. P. Loftus,A. Maurizi,A. Cappariello,M. Muraca,A. Teti

DOI: https://doi.org/10.1002/jbmr.3332

IF: 6.39

2018-03-01

Journal of Bone and Mineral Research

Abstract:Extracellular vesicles (EVs) are newly appreciated regulators of tissue homeostasis and a means of intercellular communication. Reports have investigated the role of EVs and their cargoes in cellular regulation and have tried to fine‐tune their biotechnological use, but to date very little is known on their function in bone biology. To investigate the relevance of EV‐mediated communication between bone cells, we isolated EVs from primary mouse osteoblasts and assessed membrane integrity, size, and structure by transmission electron microscopy (TEM) and fluorescence‐activated cell sorting (FACS). EVs actively shuttled loaded fluorochromes to osteoblasts, monocytes, and endothelial cells. Moreover, osteoblast EVs contained mRNAs shared with donor cells. Osteoblasts are known to regulate osteoclastogenesis, osteoclast survival, and osteoclast function by the pro‐osteoclastic cytokine, receptor activator of nuclear factor κ‐B ligand (Rankl). Osteoblast EVs were enriched in Rankl, which increased after PTH treatment. These EVs were biologically active, supporting osteoclast survival. EVs isolated from rankl–/– osteoblasts lost this pro‐osteoclastic function, indicating its Rankl‐dependence. They integrated ex vivo into murine calvariae, and EV‐shuttled fluorochromes were quickly taken up by the bone upon in vivo EV systemic administration. Rankl–/– mice lack the osteoclast lineage and are negative for its specific marker tartrate‐resistant acid phosphatase (TRAcP). Treatment of rankl–/– mice with wild‐type osteoblast EVs induced the appearance of TRAcP‐positive cells in an EV density‐dependent manner. Finally, osteoblast EVs internalized and shuttled anti‐osteoclast drugs (zoledronate and dasatinib), inhibiting osteoclast activity in vitro and in vivo. We conclude that osteoblast EVs are involved in intercellular communication between bone cells, contribute to the Rankl pro‐osteoclastic effect, and shuttle anti‐osteoclast drugs, representing a potential means of targeted therapeutic delivery. © 2017 The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals Inc.

Chemistry,Medicine,Biology
Effect of zoledronic acid on osteoprotegerin and tumor necrosis factor alpha mRNA expression in rats

Jing Bo,Yin Yun-sheng,Zhang Tao,Wang Xing-yu,Zheng Zhen-yu,Chen Xiao-min,Wen Wei-jing

DOI: https://doi.org/10.3969/j.issn.1673-8225.2011.02.021

2011-01-01

Abstract:BACKGROUND:Zoledronic acid is a new generation of diphosphate,which is the third generation of osteoporosis drugs.It is widely used to treat diseases related to increase of bone absorption in clinic.The effect of zoledronic acid on osteoclast has reached consensus,but its effect on osteoblast remains in dispute.OBJECTIVE:To observe the effect of zoledronic acid on the proliferation,differentiation and the mRNA expression of osteoprotegerin (OPG) and tumor necrosis factor α (TNF-α) of rat osteoblasts.METHODS:The osteoblasts isolated from the calvaria of neonatal SD rats were cultured with different concentrations of zoledronic acid.The final concentration of zoledronic acid in the experimental group ranged from 10-5-10-9mol/L.At 3,5,and 7 days after zoledronic acid intervention,MTT colorimetric assay was used to measure the absorbance to detect the effect of zoledronic acid on the proliferation of osteoblasts.p-nitrophenyl phosphate approach method was used to detect the activities of alkaline phosphatase,while RT-PCR was used to detect OPG and TNF-α mRNA expression.RESULTS AND CONCLUSION:Zoledronic acid at the concentration of 10-5mol/L could inhibit the proliferation of osteoblasts,but it had no effect at concentration of 10-7-10-9mol/L.Zoledronic acid at concentration of 10-5-10-9mol/L could up-regulate the OPG mRNA expression,but down-regulate TNF-α mRNA expression.Zoledronic acid at low concentration cannot influence the proliferation and differentiation of osteoblasts;whereas,it can inhibit bone resorption by regulating the OPG and TNF-α mRNA expression.
The Potential of Enamel Matrix Derivative in Countering Bisphosphonate-Induced Effects in Osteoblasts

Minah Kim,Minji Choi,Yong-Dae Kwon,Joo-Young Ohe,Junho Jung

DOI: https://doi.org/10.3390/life14091088

2024-09-01

Life

Abstract:The suppressive effect of bisphosphonates (BPs) on bone metabolism is considered to be a major cause of medication-related osteonecrosis of the jaw (MRONJ). Enamel matrix derivative (EMD) stimulates and activates growth factors, leading to the regeneration of periodontal tissues. In this study, we aimed to explore the potential of EMD in reversing the detrimental effects of BPs on human fetal osteoblasts (hFOBs) and osteosarcoma-derived immature osteoblasts (MG63s) by assessing cell viability, apoptosis, migration, gene expression, and protein synthesis. While the suppressive effect of zoledronate (Zol) on cell viability and migration was observed, the addition of EMD significantly mitigated this effect and enhanced cell viability and migration. Furthermore, an increased apoptosis rate induced by Zol was decreased with the addition of EMD. The decreased gene expression of alkaline phosphatase (ALP), osteocalcin (OC), and the receptor activator of nuclear factors kappa-B ligand (RANKL) caused by BP treatment was reversed by the co-addition of EMD to hFOB cells. This trend was also observed for ALP and bone sialoprotein (BSP) levels in MG63 cells. Furthermore, suppressed protein levels of OC, macrophage colony-stimulating factor (M-CSF), BSP, and type 1 collagen (COL1) were recovered following the addition of EMD. This finding suggests that EMD could mitigate the effects of BPs, resulting in the recovery of cell survival, migration, and gene and protein expression. However, the behavior of the osteoblasts was not fully restored, and further studies are necessary to confirm their effects at the cellular level and to assess their clinical usefulness in vivo for the prevention and treatment of MRONJ.

biology
Inhibiting Monoacylglycerol Lipase Suppresses RANKL-Induced Osteoclastogenesis and Alleviates Ovariectomy-Induced Bone Loss

Hui Liu,Chuankun Zhou,Dahu Qi,Yutong Gao,Meipeng Zhu,Tenghui Tao,Xuying Sun,Jun Xiao

DOI: https://doi.org/10.3389/fcell.2021.640867

IF: 5.5

2021-03-12

Frontiers in Cell and Developmental Biology

Abstract:Osteoporosis is a common chronic metabolic bone disease characterized by reduced trabecular bone and increased bone fragility. Monoacylglycerol lipase (MAGL) is a lipolytic enzyme to catalyze the hydrolysis of monoglycerides and specifically degrades the 2-arachidonoyl glycerol (2-AG). Previous studies have identified that 2-AG is the mainly source for arachidonic acid and the most abundant endogenous agonist of cannabinoid receptors. Considering the close relationship between inflammatory mediators/cannabinoid receptors and bone metabolism, we speculated that MAGL may play a role in the osteoclast differentiation. In the present study, we found that MAGL protein expression increased during osteoclast differentiation. MAGL knockdown by adenovirus-mediated shRNA in bone marrow-derived macrophages demonstrated the suppressive effects of MAGL on osteoclast formation and bone resorption. In addition, pharmacological inhibition of MAGL by JZL184 suppressed osteoclast differentiation, bone resorption, and osteoclast-specific gene expression. Activation of the Mitogen-activated protein kinase (MAPK) and nuclear factor κB (NF-κB) pathways was inhibited by JZL184 and deletion of MAGL. Our in vivo study indicated that JZL184 ameliorated bone loss in an ovariectomized mouse model. Furthermore, overexpressing H1 calponin partially alleviated the inhibition caused by JZL184 or MAGL deletion on osteoclastogenesis. Therefore, we conclude that targeting MAGL may be a novel therapeutic strategy for osteoporosis.

cell biology,developmental biology
Engineered osteoclasts resorb necrotic alveolar bone in anti-RANKL antibody-treated mice

Worakanya Buranaphatthana,Apichai Yavirach,Elizabeth M Leaf,Marta Scatena,Hai Zhang,Jonathan Y An,Cecilia M Giachelli,Elizabeth M. Leaf,Jonathan Y. An,Cecilia M. Giachelli

DOI: https://doi.org/10.1016/j.bone.2021.116144

IF: 4.626

2021-12-01

Bone

Abstract:Medication-related osteonecrosis of the jaw (MRONJ) is a serious side effect of antiresorptive medications such as denosumab (humanized anti-RANKL antibody), yet its pathophysiology remains elusive. It has been posited that inhibition of osteoclastic bone resorption leads to the pathological sequelae of dead bone accumulation, impaired new bone formation, and poor wound healing in MRONJ, but this hypothesis has not been definitively tested. We previously engineered myeloid precursors with a conditional receptor activator of nuclear factor kappa-Β intracellular domain (iRANK cells), which differentiate into osteoclasts in response to a chemical inducer of dimerization (CID) independently of RANKL. In this study, we showed that CID-treated iRANK cells differentiated into osteoclasts and robustly resorbed mineralized surfaces even in the presence of anti-RANKL antibody in vitro. We then developed a tooth extraction-triggered MRONJ model in nude mice using anti-RANKL antibody to deplete osteoclasts. This model was used to determine whether reconstitution of engineered osteoclasts within sockets could prevent specific pathological features of MRONJ. Locally delivered iRANK cells successfully differentiated into multinucleated osteoclasts in response to CID treatment in vivo as measured by green fluorescent protein (GFP), tartrate-resistant acid phosphatase (TRAP), carbonic anhydrase II, matrix metallopeptidase 9 (MMP-9), and cathepsin K staining. Sockets treated with iRANK cells + CID had significantly more osteoclasts and less necrotic bone than those receiving iRANK cells alone. These data support the hypothesis that osteoclast deficiency leads to accumulation of necrotic bone in MRONJ.

endocrinology & metabolism
Osteoclast-Derived Exosomal miR-5134-5p Interferes with Alveolar Bone Homeostasis by Targeting the JAK2/STAT3 Axis

Lai Pan,Chenyi Zhang,Haizheng Zhang,Ting Ke,Mengyao Bian,Yuxuan Yang,Lili Chen,Jingyi Tan

DOI: https://doi.org/10.2147/IJN.S413692

IF: 7.033

2023-07-08

International Journal of Nanomedicine

Abstract:Lai Pan, &ast Chenyi Zhang, &ast Haizheng Zhang, Ting Ke, Mengyao Bian, Yuxuan Yang, Lili Chen, Jingyi Tan Department of Periodontology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, 310009, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jingyi Tan; Lili Chen, Email ; Background: In chronic periodontitis, exosomes transport various informative substances between osteoclasts and osteoblasts in alveolar bone. Herein, we aimed to investigate the effect of exosomal micro-ribonucleic acid (miRNA/miR)-5134-5p derived from osteoclasts on osteoblastic proliferation and differentiation and the development of periodontitis in vivo and in vitro. Methods: The effects of OC-Exos on the proliferation and differentiation of osteoblasts were identified by Real-time quantitative reverse polymerase chain reaction (qRT-PCR), Western blot(WB), alkaline phosphatase(ALP) staining, etc. Exosomal miRNA expression was analyzed by sequencing. The sites of miRNA action were predicted through TargetScan and tested by double luciferase assay. After transfecting miR-5134-5p mimic/inhibitor into osteoblasts, we measured the proliferation and differentiation of osteoblasts by ALP staining and WB, etc. Furthermore, OC-Exos were injected into the gingival sulcus at the ligation site. Inflammation was observed by Hematoxylin-eosin (H&E) staining, the expression of inflammatory factors were detected by qRT-PCR, the resorption of alveolar bone was observed by Micro CT. Results: Osteoblastic proliferation and differentiation were negatively regulated by OC-Exos in vitro. miRNA sequencing analysis revealed that miR-5134-5p expression was significantly elevated in OC-Exos, which also increased in osteoblasts following OC-Exo intervention. The dual-luciferase assay revealed that miR-5134-5p and Janus kinase 2 (JAK2) had binding sites. miR-5134-5p-mimics could upregulate miR-5134-5p expression in osteoblasts while downregulating Runt-related transcription factor 2(Runx2), phosphorylated-JAK2 (p-JAK2), and phosphorylated-signal transducer and activator of transcription 3 (p-STAT3) expression and inhibited osteogenic differentiation. However, miR-5134-5p-inhibitor had the opposite effect. In vivo, the OC-Exo group demonstrated morphological disruption of periodontal tissue, massive inflammatory cell infiltration, upregulation of inflammatory factors mRNA expression, a significant decrease in BV/TV, and an increase in the cementoenamel junction and alveolar bone crest distance. Conclusion: Osteoclast-derived exosomal miR-5134-5p inhibits osteoblastic proliferation and differentiation via the JAK2/STAT3 pathway. OC-Exos exacerbate periodontal tissue inflammation and accelerate alveolar bone resorption in mice with experimental periodontitis. Keywords: exosomes, miR-5134-5p, bone homeostasis, JAK2/STAT3 pathway, osteoclast-osteoblast communication Periodontitis is a chronic infectious disease characterized by progressive alveolar bone resorption. Alveolar bone loss occurs because of inflammatory responses triggered by bacteria and their products. 1 The two basic functional cells of bone metabolism, osteoclasts, and osteoblasts, dominate the balanced dynamic process of bone resorption and formation. 2 This balance gets disturbed as periodontitis progresses. The paracrine pathway plays a crucial role in the communication between osteoblasts and osteoclasts, wherein exosomes serve as representative members. Exosomes are the membrane-bound vesicles produced in intracellular multivesicular bodies and are released into the extracellular matrix. Previous studies have reported that osteoblasts regulate bone resorption via exosomes targeting osteoclasts. 3–5 However, osteoclast-to-osteoblast crosstalk by exosomes in periodontitis lacks research. Micro-ribonucleic acids (RNAs) (miRNAs/miRs) are non-coding single-stranded RNAs comprising approximately 22 nucleotides that can identify and band to the 3'-untranslated region of target messenger RNAs (mRNAs) and reverse their expression by incomplete base pairing. 6–9 However, miRNAs are susceptible to degradation owing to their instability in the extracellular space. The exosomes incorporate, transfer, stabilize, and protect themselves from degradation. 10–12 Lv et al 13 found that miR-181b-5p delivered by osteocyte-derived exosomes promotes human periodontal ligament stem cell proliferation via the phosphatase and tensin homolog(PTEN)/protein kinase B(PKB) pathway, suggesting that miRNA-carrying exosomes are crucial for bone remodeling in periodontitis. 14,15 Hu et al 3 illustrated that sympathetic neuro-stress could drive -Abstract Truncated-

pharmacology & pharmacy,nanoscience & nanotechnology
BMSC-derived extracellular vesicles promoted osteogenesis via Axin2 inhibition by delivering MiR-16-5p

Jiaxin Duan,Hao Li,Changyuan Wang,Jialin Yao,Yue Jin,Jianyu Zhao,Yukun Zhang,Mozhen Liu,Huijun Sun

DOI: https://doi.org/10.1016/j.intimp.2023.110319

IF: 5.714

2023-05-24

International Immunopharmacology

Abstract:Osteoporosis (OP) is a systemic bone disease caused by an imbalance in osteogenesis and osteoclastic resorption. Extracellular vesicles (EVs)-encapsulated miRNAs from bone mesenchymal stem cells (BMSCs) have been reported to participate in osteogenesis. MiR-16-5p is one of the miRNAs that regulates osteogenic differentiation; however, studies have shown that its role in osteogenesis is controversial. Thus, this study aims to investigate the role of miR-16-5p from BMSC-derived extracellular vesicles (EVs) in osteogenic differentiation and uncover the underlying mechanisms. In this study, we used an ovariectomized (OVX) mouse model and an H 2 O 2 -treated BMSCs model to investigate the effects of BMSC-derived EVs and EV-encapsulated miR-16-5p on OP and the underlying mechanisms. Our results proved that the miR-16-5p level was significantly decreased in H 2 O 2 -treated BMSCs, bone tissues of OVX mice, and lumbar lamina tissues from osteoporotic women. EVs-encapsulated miR-16-5p from BMSCs could promote osteogenic differentiation. Moreover, the miR-16-5p mimics promoted osteogenic differentiation of H 2 O 2 -treated BMSCs, and the effects exerted by miR-16-5p were mediated by targeting Axin2, a scaffolding protein of GSK3β that negatively regulates the Wnt/β-catenin signaling pathway. This study provides evidence that EVs-encapsulated miR-16-5p from BMSCs could promote osteogenic differentiation by repressing Axin2.

pharmacology & pharmacy,immunology
Mesenchymal Stem Cell-Derived Extracellular Vesicles Inhibit Osteoporosis via MicroRNA-27a-Induced Inhibition of DKK2-Mediated Wnt/β-Catenin Pathway

Yan Wang,Xiaoqi Zhou,Dalin Wang

DOI: https://doi.org/10.1007/s10753-021-01583-z

Inflammation

Abstract:Osteoporosis (OP) is a systemic skeletal disease that promotes bone fragility and the risk of fractures. Recent studies have shown the relevance of microRNAs (miRNAs) in the development of OP. This study aimed to evaluate the possible mechanisms of action underlying miR-27a loaded by mesenchymal stem cell (MSC)-derived extracellular vesicles (MSC-EVs) in OP. Serum samples from OP patients and normal controls were collected for miRNA microarray analysis. The expression of filtered miRNA was upregulated in osteoblasts (OB) and osteoclasts (OCs) for biological activity assessment. After developing OP mice using ovariectomy (OVX) and confirming OP, the miR-27a expression level was upregulated in mice by MSC-EV application. Dual-luciferase assays were conducted to validate the relationship between miR-27a and DKK2 expression. The poor expression of miR-27a was observed in patients with OP. miR-27a increased the expression of OB markers, the number of ALP-positive cells, and the number of calcium nodules in OCs. In OVX mice, miR-27a increased bone density, improved bone structure damage recovery, decreased the levels of bone resorption markers, and decreased OC number. miR-27a transmitted by MSC-EVs interacted with DKK2. MSC-EVs exerted the same protective effects as miR-27a on OP, whereas miR-27a inhibitor abolished the attenuating effects of MSC-EVs. In contrast, DKK2 depletion reversed the stimulatory effects of the miR-27a inhibitor on OP. The Wnt/β-catenin pathway was activated upon MSC-EV application and DKK2 silencing and was impaired upon the downregulation of the expression of miR-27a. MSC-EVs are effective in preventing mouse OP. This mechanism is mediated by the miR-27a/DKK2/Wnt/β-catenin signaling pathway.
Antisense oligonucleotide against miR-21 inhibits migration and induces apoptosis in leukemic K562 cells

Haiyan Hu,Yumin Li,Jingyi Gu,Xujiao Zhu,D. Dong,Ju-Hsien Yao,Chunyan Lin,J. Fei

DOI: https://doi.org/10.3109/10428191003596835

2010-04-01

Abstract:MicroRNAs (miRNAs) are small non-coding RNA molecules that are widely involved in cancer-related processes. The microRNA-21 (miR-21) has been identified as the only miRNA overexpressed in a variety of cancers, including leukemia. However, the function of miR-21 is yet unknown in chronic myelogenous leukemia (CML). Antisense oligonucleotides (ASOs), as inhibitors of miRNAs, have already been applied to therapeutic development and functional identification in miRNA research. In this study, we found that the antisense inhibition of miR-21 in K562 cells suppressed cell migration, promoted cell apoptosis, and inhibited cell growth, and up-regulated the expression of the tumor suppressor gene PDCD4. Meanwhile, pre-miRNA-21 increased migration and decreased cell apoptosis without affecting proliferation. We also validated that PDCD4 is a functional target of miR-21 in K562 cells. These effects of miR-21 might be partially due to its regulation of PDCD4. Our data suggest that miR-21 may play an oncogenic role in the cellular processes of CML, and antisense inhibition of miR-21 may therefore be useful as CML therapy.
Characterization of novel hsp70 in mammalian cells.

R. Anderson,D. Naylor,T. Gabriele,T. Tetaz,P. Høj

DOI: https://doi.org/10.3109/02656739409010287

1994-05-01

International Journal of Hyperthermia

Abstract:A new protein detected in heat resistant mutants of a murine fibrosarcoma has been identified as a member of the hsp70 family. The protein is similar to the constitutive hsp70 of the parent cells with regard to its antibody cross-reactivity, its ability to bind to an ATP affinity column and partial amino acid sequencing. It is present in addition to, and in similar amounts to, the constitutive isoform of the heat resistant mutant cells and the parent cell line. The lack of either of two post-translational modifications common to other hsps, phosphorylation and ADP-ribosylation, and the demonstration of mRNA for the novel protein suggest that it is a separate gene product and not a post-translational modification of the constitutive hsp70. To our knowledge, this protein has not been described in other systems and may be important in the expression of the heat resistant phenotype of these cells. The in vivo phosphorylation patterns also show that hsp90 and hsp28 are heavily phosphorylated in the heat resistant mutant, but that two other stress proteins reported to be phosphorylated under some conditions are not phosphorylated in these cells.
miR-134-5p inhibits osteoclastogenesis through a novel miR-134-5p/Itgb1/MAPK pathway

Meng Huang,Yan Wang,Zhenning Wang,Qiaozhen Qin,Heyang Zhang,Shuirong Liu,Jiantong Cui,Yu Zhang,Xiaoxia Jiang,Lulu Xu

DOI: https://doi.org/10.1016/j.jbc.2022.102116

IF: 5.485

2022-07-01

Journal of Biological Chemistry

Abstract:Osteoporosis affects approximately 200 million people and severely affects quality of life, but the exact pathological mechanisms behind this disease remain unclear. Various miRNAs have been shown to play a predominant role in the regulation of osteoclast formation. In this study, we explored the role of miR-134-5p in osteoclastogenesis both in vivo and in vitro. We constructed an ovariectomized (OVX) mouse model and performed microarray analysis using bone tissue from OVX mice and their control counterparts. Quantitative RT-PCR data from bone tissue and bone marrow macrophages (BMMs) confirmed the decreased expression of miR-134-5p in OVX mice observed in microarray analysis. In addition, a decrease in miR-134-5p was also observed during induced osteoclastogenesis of BMMs collected from C57BL/6N mice. Through transfection with miR-134-5p agomirs and antagomirs, we found that miR-134-5p knockdown significantly accelerated osteoclast formation and cell proliferation and inhibited apoptosis. Furthermore, a luciferase reporter assay showed that miR-134-5p directly targets the integrin surface receptor gene Itgb1. Cotransfection with Itgb1 siRNA reversed the effect of the miR-134-5p antagomir in promoting osteoclastogenesis. Moreover, the abundance levels of MAPK pathway proteins phosphorylated-p38 (p-p38) and phosphorylated-ERK (p-ERK) were significantly increased after transfection with the miR-134-5p antagomir but decreased after transfection with the miR-134-5p agomir or Itgb1 siRNA, which indicated a potential relationship between the miR-134-5p/Itgb1 axis and the MAPK pathway. Collectively, these results revealed that miR-134-5p inhibits osteoclast differentiation of BMMs both in vivo and in vitro and that the miR-134-5p/Itgb1/MAPK pathway might be a potential target for osteoporosis therapy.

biochemistry & molecular biology
Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrow in vivo: role in osteoclast-mediated NK cell activation

Han-Ching Tseng,Keiichi Kanayama,Kawaljit Kaur,So-Hyun Park,Sil Park,Anna Kozlowska,Shuting Sun,Charles E McKenna,Ichiro Nishimura,Anahid Jewett

DOI: https://doi.org/10.18632/oncotarget.4755

2015-08-21

Oncotarget

Abstract:The aim of this study is to establish osteoclasts as key immune effectors capable of activating the function of Natural Killer (NK) cells, and expanding their numbers, and to determine in vivo and in vitro effect of bisphosphonates (BPs) during NK cell interaction with osteoclasts and on systemic and local immune function. The profiles of 27 cytokines, chemokines and growth factors released from osteoclasts were found to be different from dendritic cells and M1 macrophages but resembling to untreated monocytes and M2 macrophages. Nitrogen-containing BPs Zoledronate (ZOL) and Alendronate (ALN), but not non-nitrogen-containing BPs Etidronate (ETI), triggered increased release of pro-inflammatory mediators from osteoclasts while all three BPs decreased pit formation by osteoclasts. ZOL and ALN mediated significant release of IL-6, TNF-` and IL-1β, whereas they inhibited IL-10 secretion by osteoclasts. Treatment of osteoclasts with ZOL inhibited NK cell mediated cytotoxicity whereas it induced significant secretion of cytokines and chemokines. NK cells lysed osteoclasts much more than their precursor cells monocytes, and this correlated with the decreased expression of MHC class I expression on osteoclasts. Intravenous injection of ZOL in mice induced pro-inflammatory microenvironment in bone marrow and demonstrated significant immune activation. By contrast, tooth extraction wound of gingival tissues exhibited profound immune suppressive microenvironment associated with dysregulated wound healing to the effect of ZOL which could potentially be responsible for the pathogenesis of Osteonecrosis of the Jaw (ONJ). Finally, based on the data obtained in this paper we demonstrate that osteoclasts can be used as targets for the expansion of NK cells with superior function for immunotherapy of cancer.
Characterization of Regulatory Extracellular Vesicles from Osteoclasts

N Huynh,L VonMoss,D Smith,I Rahman,M F Felemban,J Zuo,W J Rody Jr,K P McHugh,L S Holliday

DOI: https://doi.org/10.1177/0022034516633189

Abstract:Extracellular vesicles (EVs), which include exosomes and ectosomes/microvesicles, have emerged as important intercellular regulators. EVs can interact with surface receptors of target cells and can transport luminal components, including messenger RNAs (mRNAs), microRNAs, and enzymes, to the cytosol of the target cell. Here, we show that hematopoietic cells grown in culture shed exosome-like EVs as they differentiate from preosteoclasts into osteoclasts. These EVs were between 25 and 120 nm (mean, 40 nm) in diameter determined by transmission electron microscopy. The exosome-associated markers CD63 and EpCAM were enriched in the isolated EVs while markers of Golgi and endoplasmic reticulum were not detected. Treatment of isolated hematopoietic cells with EVs did not affect their receptor activator of nuclear factor κB-ligand (RANKL)-stimulated differentiation into osteoclasts. However, EVs from osteoclast precursors promoted 1,25-dihydroxyvitamin D3-dependent osteoclast formation in whole mouse marrow cultures, and EVs from osteoclast-enriched cultures inhibited osteoclastogenesis in the same cultures. These data suggested that osteoclast-derived EVs are paracrine regulators of osteoclastogenesis. EVs from mature osteoclasts contained receptor activator of nuclear factor κB (RANK). Immunogold labeling showed RANK was enriched in 1 in every 32 EVs isolated from osteoclast-enriched cultures. Depletion of RANK-rich EVs relieved the ability of osteoclast-derived EVs to inhibit osteoclast formation in 1,25-dihydroxyvitamin D3-stimulated marrow cultures. In summary, we show for the first time that EVs released by osteoclasts are novel regulators of osteoclastogenesis. Our data suggest that RANK in EVs may be mechanistically linked to the inhibition of osteoclast formation. RANK present in EVs may function by competitively inhibiting the stimulation of RANK on osteoclast surfaces by RANKL similar to osteoprotegerin. RANK-rich EVs may also take advantage of the RANK/RANKL interaction to target RANK-rich EVs to RANKL-bearing cells for the delivery of other regulatory molecules.
Exosome-targeted delivery of METTL14 regulates NFATc1 m6A methylation levels to correct osteoclast-induced bone resorption

Jin-Gang Yang,Bao Sun,Zheng Wang,Xing Li,Jia-hui Gao,Jia-jun Qian,Jiang Li,Wen-jia Wei,Ping Zhang,Wei Wang

DOI: https://doi.org/10.1038/s41419-023-06263-4

2023-11-14

Cell Death and Disease

Abstract:Osteoporosis has a profound influence on public health. First-line bisphosphonates often cause osteonecrosis of the jaw meanwhile inhibiting osteoclasts. Therefore, it is important to develop effective treatments. The results of this study showed that the increased level of NFATc1 m6A methylation caused by zoledronic acid (ZOL), with 4249A as the functional site, is highly correlated with the decreased bone resorption of osteoclasts. Upstream, METTL14 regulates osteoclast bone absorption through the methylation functional site of NFATc1. Downstream, YTHDF1 and YTHDF2 show antagonistic effects on the post-transcriptional regulation of NFATc1 after the m6A methylation level is elevated by METTL14. In this study, meRIP-Seq, luciferase reporter assays, meRIP and other methods were used to elucidate the NFATc1 regulatory mechanism of osteoclasts from the perspective of RNA methylation. In addition, EphA2 overexpression on exosomes is an effective biological method for targeted delivery of METTL14 into osteoclasts. Importantly, this study shows that METTL14 released by exosomes can increase the m6A methylation level of NFATc1 to inhibit osteoclasts, help postmenopausal osteoporosis patients preserve bone mass, and avoid triggering osteonecrosis of the jaw, thus becoming a new bioactive molecule for the treatment of osteoporosis.

cell biology
Osteoclast-derived extracellular miR-106a-5p promotes osteogenic differentiation and facilitates bone defect healing

Yutong Wu,Hongbo Ai,Yuchi Zou,Qiankun Yang,Ce Dou,Jianzhong Xu

DOI: https://doi.org/10.1016/j.cellsig.2022.110549

IF: 4.85

2022-12-03

Cellular Signalling

Abstract:Small extracellular vesicles (sEVs) are considered to play critical roles in intercellular communications during normal and pathological processes since they are enriched with miRNAs and other signal molecules. In bone remodeling, osteoclasts generate large amounts of sEVs. However, there is very few research studying whether and how osteoclast-derived sEVs (OC-sEVs) affect surrounding cells. In our study, microarray analysis identified miR-106a-5p as highly enriched in OC-sEV. Further experiments confirmed that OC-sEVs inhibited Fam134a through miR-106a-5p and significantly promoted bone mesenchymal stem cell (BMSC) osteogenic mineralization in vitro . Next, we prepared an sEV-modified demineralized bone matrix (DBM) as scaffold treating calvarial defect mouse model to evaluate the pro-osteogenic activities of the scaffold. In vivo results indicated that DBM modified with miR-106a-5p-sEVs showed an enhanced capacity for bone regeneration. This important finding further emphasizes that sEV-mediated miR-106a-5p transfer plays a critical role in osteogenesis and indicates a novel communication mode between osteoclasts and BMSCs.

cell biology
Exosomes Derived from Adipose Tissue-Derived Mesenchymal Stromal Cells Prevent Medication-Related Osteonecrosis of the Jaw through IL-1RA

Yi Zheng,Xian Dong,Xinyu Wang,Jie Wang,Shuo Chen,Yang He,Jingang An,Linhai He,Yi Zhang

DOI: https://doi.org/10.3390/ijms24108694

2023-05-12

Abstract:Medication-related osteonecrosis of the jaw (MRONJ) is a severe disease with unclear pathogenesis. Adipose tissue-derived mesenchymal stromal cells (MSC(AT)s) serve as a special source for cell therapy. Herein, we explored whether exosomes (Exo) derived from MSC(AT)s promote primary gingival wound healing and prevent MRONJ. An MRONJ mice model was constructed using zoledronate (Zol) administration and tooth extraction. Exosomes were collected from the conditioned medium (CM) of MSC(AT)s (MSC(AT)s-Exo) and locally administered into the tooth sockets. Interleukin-1 receptor antagonist (IL-1RA)-siRNA was used to knock down the expression of IL-1RA in MSC(AT)s-Exo. Clinical observations, micro-computed tomography (microCT), and histological analysis were used to evaluate the therapeutic effects in vivo. In addition, the effect of exosomes on the biological behavior of human gingival fibroblasts (HGFs) was evaluated in vitro. MSC(AT)s-Exo accelerated primary gingival wound healing and bone regeneration in tooth sockets and prevented MRONJ. Moreover, MSC(AT)s-Exo increased IL-1RA expression and decreased interleukin-1 beta (IL-1β) and tumor necrosis factor-α (TNF-α) expression in the gingival tissue. The sequent rescue assay showed that the effects of preventing MRONJ in vivo and improving the migration and collagen synthesis abilities of zoledronate-affected HGFs in vitro were partially impaired in the IL-1RA-deficient exosome group. Our results indicated that MSC(AT)s-Exo might prevent the onset of MRONJ via an IL-1RA-mediated anti-inflammatory effect in the gingiva wound and improve the migration and collagen synthesis abilities of HGFs.
Nanoengineering multifunctional extracellular vesicles availably mitigate bone loss in osteoporosis through binding to RANKL and rebalancing the Treg/Th17 cells

Zhengyu Yang,Zhen Yang,Lin Ding,Cong Liu,Fujian Zhao,Xiaofeng Chen,Chang Du

DOI: https://doi.org/10.1016/j.cej.2023.143391

IF: 15.1

2023-05-17

Chemical Engineering Journal

Abstract:The balance between regulatory T cells (Treg) and T helper 17 cells (Th17) plays an important role in bone loss in osteoporosis. Hyperactivation of Th17 cells, where a large amount of cytokine RANKL is secreted, promotes the osteoclast phenotype. The restoration of immune homeostasis of Treg/Th17 cells could inhibit bone loss. However, the engineered strategy is still absent. Herein, we report an immunomodulatory bioactive glass nanoparticle-engineered bone marrow-derived macrophages (BMDMs) to generate extracellular vesicles (SrBGN + Mφ-EVs), which could regulate the Treg/Th17 balance and inhibit the bone loss in osteoporosis. SrBGN + Mφ-EVs contain both SrBGNs immunomodulatory active ions and anti-inflammatory factors of M2-type BMDMs and have good biocompatibility in vitro . SrBGN + Mφ-EVs regulated the Treg/Th17 balance by promoting Treg cell differentiation and inhibiting Th17 cell differentiation in vitro . More importantly, more RANK was enriched on the surface of SrBGN + Mφ-EVs with strong affinity to RANKL, which acted as a competitive inhibitor of RANKL-RANK interaction and inhibited the activation of osteoclasts. In vivo experiments, SrBGN + Mφ-EVs showed excellent biocompatibility and improved the immune environment of osteoporotic mice to inhibit bone loss. This study may provide new ideas for the regulatory strategy of bioactive glass and its engineered extracellular vesicles in re-establishing immune homeostasis in osteoporosis, as well as a solution for treating bone resorption disorders.

engineering, chemical, environmental

"Humor book" provides release for nurses.

Cycles of Learning in the Centipede Game

Osteoclast-derived Exosomal Mir-214-3p Inhibits Osteoblastic Bone Formation.

Effect of primary osteoblast-derived extracellular vesicles on osteoclast differentiation

Osteoblast‐Derived Extracellular Vesicles Are Biological Tools for the Delivery of Active Molecules to Bone

Effect of zoledronic acid on osteoprotegerin and tumor necrosis factor alpha mRNA expression in rats

The Potential of Enamel Matrix Derivative in Countering Bisphosphonate-Induced Effects in Osteoblasts

Inhibiting Monoacylglycerol Lipase Suppresses RANKL-Induced Osteoclastogenesis and Alleviates Ovariectomy-Induced Bone Loss

Engineered osteoclasts resorb necrotic alveolar bone in anti-RANKL antibody-treated mice

Osteoclast-Derived Exosomal miR-5134-5p Interferes with Alveolar Bone Homeostasis by Targeting the JAK2/STAT3 Axis

BMSC-derived extracellular vesicles promoted osteogenesis via Axin2 inhibition by delivering MiR-16-5p

Mesenchymal Stem Cell-Derived Extracellular Vesicles Inhibit Osteoporosis via MicroRNA-27a-Induced Inhibition of DKK2-Mediated Wnt/β-Catenin Pathway

Antisense oligonucleotide against miR-21 inhibits migration and induces apoptosis in leukemic K562 cells

Characterization of novel hsp70 in mammalian cells.

miR-134-5p inhibits osteoclastogenesis through a novel miR-134-5p/Itgb1/MAPK pathway

Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrow in vivo: role in osteoclast-mediated NK cell activation

Characterization of Regulatory Extracellular Vesicles from Osteoclasts

Exosome-targeted delivery of METTL14 regulates NFATc1 m6A methylation levels to correct osteoclast-induced bone resorption

Osteoclast-derived extracellular miR-106a-5p promotes osteogenic differentiation and facilitates bone defect healing

Exosomes Derived from Adipose Tissue-Derived Mesenchymal Stromal Cells Prevent Medication-Related Osteonecrosis of the Jaw through IL-1RA

Nanoengineering multifunctional extracellular vesicles availably mitigate bone loss in osteoporosis through binding to RANKL and rebalancing the Treg/Th17 cells